Replies to post #203080 on Innovation Pharmaceuticals Inc (IPIX)

[58nout]

More nonsense. This with what we know can go as far as 74 million dollars will take it and that's without any additional financing. Read the filing.

[TheHound]

the company dilutes as needed to fund the company and they've been very frugal in their efforts compared to most bio's i follow.

last quarter was well above historical averages due to the # of trials being finalized. if you were to look at historical averages, the number ur hanging ur hat on would probably drop by half.

the number as presented is also a function of volume.

[sox040713]

The Aruda selling sounded like fake news, that's why I asked for a source. I guess we don't need to wait long to find out how much he has sold, if any, this year in the next filing.

Dilutions are expected in pre-revenue biotechs. If that's the reason not to buy, then maybe a biotech with no clinical trial, therefore little dilutions, is a better choice. 1.63% increase in OS in the last quarter is acceptable to me for a company with three active Phase 2 trials.

[baytdr]

I would prefer that Leo negotiate more private placements with investors inclined to hold longer term based upon the prospects of the trials and platforms. The last PP investors most likely haven't sold.